Caterina Alati

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 208 citations · Full text

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 159 citations · Full text

Eltrombopag Versus Placebo, Thrombosis, Thrombopoiesis +7

Iron chelation therapy associated with improvement of hematopoiesis in transfusion‐dependent patients

Esther Natalie Olíva, Francesca Ronco, Antonio Marino et al. · Transfusion · 2010 · 76 citations

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Fabio Guolo, Luana Fianchi, Paola Minetto et al. · Blood Cancer Journal · 2020 · 56 citations · Full text

Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life

Esther Natalie Olíva, Francesco Nobile, Giuliana Alimena et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 41 citations